These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35429212)

  • 1. Interleukin-6 signaling requires EHD1-mediated alteration of membrane rafts.
    Woo JH; Park SJ; Park SM; Joe EH; Jou I
    FEBS J; 2022 Oct; 289(19):5914-5932. PubMed ID: 35429212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservation of functional sites on interleukin-6 and implications for evolution of signaling complex assembly and therapeutic intervention.
    Veverka V; Baker T; Redpath NT; Carrington B; Muskett FW; Taylor RJ; Lawson AD; Henry AJ; Carr MD
    J Biol Chem; 2012 Nov; 287(47):40043-50. PubMed ID: 23027872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6 controls the innate immune response against Listeria monocytogenes via classical IL-6 signaling.
    Hoge J; Yan I; Jänner N; Schumacher V; Chalaris A; Steinmetz OM; Engel DR; Scheller J; Rose-John S; Mittrücker HW
    J Immunol; 2013 Jan; 190(2):703-11. PubMed ID: 23241882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and characterization of a monoclonal antibody targeting a conformational epitope of IL-6/IL-6Rα to inhibit IL-6/ IL-6Rα/gp130 hexameric signaling complex formation.
    Chou CC; Hua KT; Chen MW; Wu CJ; Hsu CH; Wang JT; Hsiao M; Wei LH
    MAbs; 2022; 14(1):2029675. PubMed ID: 35133941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fusion protein of the gp130 and interleukin-6Ralpha ligand-binding domains acts as a potent interleukin-6 inhibitor.
    Ancey C; Küster A; Haan S; Herrmann A; Heinrich PC; Müller-Newen G
    J Biol Chem; 2003 May; 278(19):16968-72. PubMed ID: 12646580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine signaling: STATS in plasma membrane rafts.
    Sehgal PB; Guo GG; Shah M; Kumar V; Patel K
    J Biol Chem; 2002 Apr; 277(14):12067-74. PubMed ID: 11815625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro reconstitution of recognition and activation complexes between interleukin-6 and gp130.
    Chow D; Ho J; Nguyen Pham TL; Rose-John S; Garcia KC
    Biochemistry; 2001 Jun; 40(25):7593-603. PubMed ID: 11412113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to IL-6 trans- and IL-6 classic signalling is determined by the ratio of the IL-6 receptor α to gp130 expression: fusing experimental insights and dynamic modelling.
    Reeh H; Rudolph N; Billing U; Christen H; Streif S; Bullinger E; Schliemann-Bullinger M; Findeisen R; Schaper F; Huber HJ; Dittrich A
    Cell Commun Signal; 2019 May; 17(1):46. PubMed ID: 31101051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling.
    Baran P; Nitz R; Grötzinger J; Scheller J; Garbers C
    J Biol Chem; 2013 May; 288(21):14756-68. PubMed ID: 23564454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical proximity and functional cooperation of glycoprotein 130 and glycoprotein VI in platelet membrane lipid rafts.
    Houck KL; Yuan H; Tian Y; Solomon M; Cramer D; Liu K; Zhou Z; Wu X; Zhang J; Oehler V; Dong JF
    J Thromb Haemost; 2019 Sep; 17(9):1500-1510. PubMed ID: 31145836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raft platforms highly enriched in cholesterol: major scaffolds for IL-6 signalling assembly with implications in inflammation and cancer.
    Mollinedo F
    FEBS J; 2022 Oct; 289(19):5891-5894. PubMed ID: 35727702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting Interleukin-6 Classic and Trans-signaling in Inflammation and Cancer.
    Garbers C; Rose-John S
    Methods Mol Biol; 2023; 2691():207-224. PubMed ID: 37355548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the Interleukin (IL)-6 Inhibitor IL-6-RFP: fused receptor domains act as high affinity cytokine-binding proteins.
    Metz S; Wiesinger M; Vogt M; Lauks H; Schmalzing G; Heinrich PC; Müller-Newen G
    J Biol Chem; 2007 Jan; 282(2):1238-48. PubMed ID: 17085445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. n-3 PUFAs reduce T-helper 17 cell differentiation by decreasing responsiveness to interleukin-6 in isolated mouse splenic CD4⁺ T cells.
    Allen MJ; Fan YY; Monk JM; Hou TY; Barhoumi R; McMurray DN; Chapkin RS
    J Nutr; 2014 Aug; 144(8):1306-13. PubMed ID: 24944284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex N-linked glycans on Asn-89 of Kaposi sarcoma herpes virus-encoded interleukin-6 mediate optimal function by affecting cytokine protein conformation.
    Dela Cruz CS; Viswanathan SR; El-Guindy AS; Shedd D; Miller G
    J Biol Chem; 2009 Oct; 284(43):29269-82. PubMed ID: 19690161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble gp130 prevents interleukin-6 and interleukin-11 cluster signaling but not intracellular autocrine responses.
    Lamertz L; Rummel F; Polz R; Baran P; Hansen S; Waetzig GH; Moll JM; Floss DM; Scheller J
    Sci Signal; 2018 Oct; 11(550):. PubMed ID: 30279168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different Soluble Forms of the Interleukin-6 Family Signal Transducer gp130 Fine-tune the Blockade of Interleukin-6 Trans-signaling.
    Wolf J; Waetzig GH; Chalaris A; Reinheimer TM; Wege H; Rose-John S; Garbers C
    J Biol Chem; 2016 Jul; 291(31):16186-96. PubMed ID: 27226573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble IL-6 receptor induces calcium flux and selectively modulates chemokine expression in human dermal fibroblasts.
    Spörri B; Müller KM; Wiesmann U; Bickel M
    Int Immunol; 1999 Jul; 11(7):1053-8. PubMed ID: 10383937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An epithelial gene signature of trans-IL-6 signaling defines a subgroup of type 2-low asthma.
    El-Husseini ZW; Khalenkow D; Lan A; van der Molen T; Brightling C; Papi A; Rabe KF; Siddiqui S; Singh D; Kraft M; Beghe B; van den Berge M; van Gosliga D; Nawijn MC; Rose-John S; Koppelman GH; Gosens R
    Respir Res; 2023 Dec; 24(1):308. PubMed ID: 38062491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of cholesterol-rich lipid rafts in interleukin-6-induced neuroendocrine differentiation of LNCaP prostate cancer cells.
    Kim J; Adam RM; Solomon KR; Freeman MR
    Endocrinology; 2004 Feb; 145(2):613-9. PubMed ID: 14563701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.